Transthyretin targeting siRNA therapeutic (Argo Biopharma)

N/A

Report date: 2024/03/05 14:42:36
NME

Base Information

Drug NameTransthyretin targeting siRNA therapeutic (Argo Biopharma)
Drug Alias NameTTR siRNA (Argo Biopharma)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransthyretin modulators
TargetsTransthyretin
Therapy Area/IndicationsTransthyretin amyloidosisStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Argo Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTransthyretin amyloidosisStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A